Dr. James Berenson - Multiple Myeloma Specialist

08/23/2025

💪"Exactly 3 years ago I was diagnosed with MM. I just wanted to say thank you to Dr. Berenson and his staff for providing me with the best care that allows me to have a great quality of life. Simply put Dr. B. you kept your word when we first met when you stated how important it was to you that your patients experience the best quality of life as they battle their cancer."👏 Picture is Mark celebrating his three years by taking a 4.5 mile hike near Lake Tahoe.

08/18/2025

What a great team. BerensonCancerCenter.com
IMBCR.org ONCOtherapeutics.com ONCOtracker.com

Happy Holidays from Berenson Cancer Center and the Institute for Myeloma & Bone Cancer Research. May 2024 be filled with good health and happiness.
IMBCR.org/Donate

08/14/2025

Birthday fun at the office. Thank you everybody for your good wishes. 🥳
IMBCR.org BerensonCancerCenter.com ONCOtherapeutics.com ONCOtracker.com

08/01/2025

Let's support an important cause: CANCER RESEARCH! For my birthday, I am raising support for the groundbreaking work that the Institute for Myeloma & Bone Cancer Research (IMBCR) is conducting everyday. We have recently discovered a new target, i1, and compounds that block it which is leading to a brand-new approach to treating myeloma. Any gift will make an impact and is tax-deductible. We appreciate you and thank you for your donation. IMBCR.org/Donate

07/17/2025

📣 UPDATE on the new myeloma treatment we’ve all been working on: We’ve gotten a lot of questions asking if the new treatment we’re working on with the Institute for Myeloma & Bone Cancer Research will eventually be available outside of the US. Here’s Dr. B’s answer.

07/04/2025

We are continuing to get lots of questions about the new treatment we’re working on for getting rid of myeloma. The first question I’m going to answer is from David on Facebook. He asks “Is the new treatment you’re testing similar to ruxolitinib or something completely new?”

Institute for Myeloma & Bone Cancer Research

06/10/2025

We started Myeloma BioBank to help accelerate the discovery of new treatments and cures for myeloma and its related diseases; this BioBank provides support for ongoing research at the Institute for Myeloma & Bone Cancer Research (IMBCR).

We are able to provide researchers with the highest quality blood and bone marrow samples from multiple myeloma and other plasma cell dyscrasias, including MGUS, amyloidosis, and Waldenstrom’s macroglobulinemia.

06/02/2025

HURRY - IMBCR's Auction to Help Support Cancer Research is Over TODAY at 5 PM. Email "Info@IMBCR.org with your name, Bid Number, & Bid. Good luck!

06/02/2025

HURRY--Almost over...IMBCR's Auction to help Support our Mission to Cure Cancer. Email "Info@ IMBCR.org" with your Name, Item Number, & Bid. Good luck!

05/27/2025

What a wonderful evening celebrating the Institute for Myeloma & Bone Cancer Research’s (IMBCR’s) groundbreaking discoveries while honoring Beverly and Eleda Cohen. The sold out event was so much fun - live music, a fabulous silent auction, and a delicious dinner shared amongst friends, colleagues, and patients. I explained what IMBCR is and does and some of the exciting research that the scientists have discovered in a lecture “Myeloma 101.”

05/11/2025

5 States of Myeloma: ⬇️

There are 5 different states of Myeloma disease. Have you heard of all of these?

🔹 1. MGUS: Stands for monoclonal gammopathy of undetermined significance. MGUS is when M-protein is found in the body, but there are not enough plasma cells to call it myeloma, and no treatment is required.

🔹2. Smoldering Myeloma: This is when there are enough plasma cells in the bone marrow (more than 10%) to call it myeloma, but there are no symptoms. Patients typically just require close monitoring.

🔹3. Plasmacytoma: is when a single group of abnormal plasma cells grow.

🔹4. Active myeloma: is where there are typically multiple symptoms, such as bone damage, fatigue, kidney failure, anemia, and a compromised immunity.

🔹5. Plasma Cell Leukemia: When the myeloma spreads from the bone marrow into the blood, it is known as plasma cell leukemia. Myeloma patients who develop this at diagnosis have a better outcome than those who develop it during the course of their disease.

No matter what stage, there are more treatments available now than ever before. 🎉
Give us a call at 310.623.1222 to schedule a consultation. 📞

05/06/2025

🎟️Tickets are going fast for this fabulous benefit! 🎉You don’t wanna miss an incredible evening filled with terrific silent auction items, three unbelievable raffle items, live music, delicious dinner while supporting cancer research. 💪 Call 310-623-1214, Email bboykin@IMBCR.org, or IMBCR.org/Events.